Read the full article, Rate of Recurrent Guillain-BarrΓ© Syndrome After mRNA COVID-19 Vaccine BNT162b2, (Jama Neurology).
Other Articles You May Like
July 9, 2026
CIDP Real-World Experience
Research Study Opportunity: CIDP Real-World Experience A new research study is enrolling adults with chronicβ¦
July 8, 2026
Guillain-BarrΓ© Syndrome Emergency Relief ProgramΒ
Making an Impact for RARE: Guillain-BarrΓ© Syndrome Emergency Relief ProgramΒ The Guillain-BarrΓ© Syndrome (GBS) Emergencyβ¦
July 1, 2026
LONDC & ANF Launch βWhy Behind Your Weaknessβ Campaign
Weβre excited to announce that the Late-Onset Neuromuscular Disease Consortium (LONDC) and ANF launched theβ¦